BEIJING: The Chinese drugmaker Sinopharm says a subsidiary has received approval for clinical trials of a new vaccine specifically to target the Omicron coronavirus variant.
Music
Trailers
DailyVideos
India
Pakistan
Afghanistan
Bangladesh
Srilanka
Nepal
Thailand
StockMarket
Business
Technology
Startup
Trending Videos
Coupons
Football
Search
Download App in Playstore
Download App
Best Collections